• SENSEX
    NIFTY 50
Healthcare

Kiran Mazumdar Shaw of Biocon and oncologist Siddhartha Mukherjee bring CAR T-cell therapy to cancer patients in India; Find all the details here

Updated : September 17, 2019 06:45 AM IST

Chimeric Antigen Receptor (CAR) T-cell therapy is currently not available in India.
In the US, two drugs approved for this therapy are sold for nearly Rs 3 crore per person.
Working on reducing the price of this drug in India by tenfold.
Kiran Mazumdar Shaw of Biocon and oncologist Siddhartha Mukherjee bring CAR T-cell therapy to cancer patients in India; Find all the details here

You May Also Like

Live TV

recommended for you

Advertisement